422 related articles for article (PubMed ID: 23289182)
21. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF
Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926
[TBL] [Abstract][Full Text] [Related]
22. Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Jensen JS; Bjerre M
Am Heart J; 2012 Nov; 164(5):786-92. PubMed ID: 23137511
[TBL] [Abstract][Full Text] [Related]
23. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).
Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W
Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313
[TBL] [Abstract][Full Text] [Related]
26. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction.
Çanga A; Durakoğlugil ME; Erdoğan T; Kirbaş A; Yilmaz A; Çiçek Y; Ergül E; Çetin M; Kocaman SA
J Cardiol; 2012 Nov; 60(5):355-60. PubMed ID: 22727437
[TBL] [Abstract][Full Text] [Related]
28. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
Moldoveanu E; Mut-Vitcu B; Tanaseanu GR; Marta DS; Manea G; Kosaka T; Vidulescu C; Tanaseanu C
Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
[TBL] [Abstract][Full Text] [Related]
29. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Zhao L; Wang L; Zhang Y
J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
[TBL] [Abstract][Full Text] [Related]
30. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
[TBL] [Abstract][Full Text] [Related]
31. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
[TBL] [Abstract][Full Text] [Related]
32. Direct ambulance transport to catheterization laboratory reduces door-to-balloon time in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the DIRECT-STEMI study.
Qiu JP; Zhang Q; Lu JD; Wang HR; Lin J; Ge ZR; Zhang RY; Shen WF
Chin Med J (Engl); 2011 Mar; 124(6):805-10. PubMed ID: 21518584
[TBL] [Abstract][Full Text] [Related]
33. Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction.
Woudstra P; Damman P; Kuijt WJ; Kikkert WJ; Grundeken MJ; van Brussel PM; Stroobants AK; van Straalen JP; Fischer JC; Koch KT; Henriques JP; Piek JJ; Tijssen JG; de Winter RJ
PLoS One; 2014; 9(5):e96251. PubMed ID: 24788873
[TBL] [Abstract][Full Text] [Related]
34. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
Rigattieri S; Biondi-Zoccai G; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Loschiavo P
J Interv Cardiol; 2008 Feb; 21(1):1-7. PubMed ID: 18086133
[TBL] [Abstract][Full Text] [Related]
35. Frequency of infarct-related artery with myocardial bridging in patients with ST-elevation myocardial infarction and its impact upon percutaneous coronary intervention.
Yan HB; Wang J; Zhu XL; Gao H; Li N; Ai H
Chin Med J (Engl); 2006 Apr; 119(7):539-43. PubMed ID: 16620693
[TBL] [Abstract][Full Text] [Related]
36. [Single lead ST-segment resolution in acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: prognostic impact and associated factors].
Zhang DP; Yang XC; Wang LF; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Luan YY; Xue YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):227-32. PubMed ID: 17582286
[TBL] [Abstract][Full Text] [Related]
37. [Distribution of lipoprotein associated phospholipase A2 in Czech population and its interaction with conventional cardiovascular risk].
Mayer O; Seidlerová J; Wohlfart P; Trefil L; Bruthans J; Filipovský J; Cífková R
Vnitr Lek; 2013 May; 59(5):344-51. PubMed ID: 23767446
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).
Antoni ML; Hoogslag GE; Boden H; Liem SS; Boersma E; Fox K; Schalij MJ; Bax JJ; Delgado V
Am J Cardiol; 2012 Jan; 109(2):187-94. PubMed ID: 22244127
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis.
Verdoia M; Rolla R; Gioscia R; Rognoni A; De Luca G;
J Thromb Thrombolysis; 2023 Jul; 56(1):37-44. PubMed ID: 37022507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
